Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective

Since the 1950s, gradual changes in the gut microbiota of patients with hepatic encephalopathy have been observed. Previous research has indicated potential associations between the gut and brain, and the gut microbiota is becoming a hot topic in research on diseases of the nervous system. However,...

Full description

Bibliographic Details
Main Authors: Jiachen Liu, Yantao Xu, Bimei Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2021.586427/full
_version_ 1819050484210597888
author Jiachen Liu
Yantao Xu
Bimei Jiang
author_facet Jiachen Liu
Yantao Xu
Bimei Jiang
author_sort Jiachen Liu
collection DOAJ
description Since the 1950s, gradual changes in the gut microbiota of patients with hepatic encephalopathy have been observed. Previous research has indicated potential associations between the gut and brain, and the gut microbiota is becoming a hot topic in research on diseases of the nervous system. However, for the past few decades, studies of hepatic encephalopathy have been restricted to controlling the gut microbiota during macroscopic manipulation, such as probiotic intervention, while its clinical use remains controversial, and the cellular mechanisms underlying this condition are still poorly understood. This thesis seeks to comprehensively understand and explain the role of gut microbiota in hepatic encephalopathy as well as analyze the effects of intervention by regulating the gut microbiota. Evidence is presented that shows that dysbiosis of the gut microbiota is the primary pathological driver of hepatic encephalopathy and impacts pathologic progression via complex regulatory networks. As a result, suggestions were identified for future mechanistic research and improvements in therapeutic strategies for hepatic encephalopathy.
first_indexed 2024-12-21T11:48:47Z
format Article
id doaj.art-5b62a20099a541be9b7374f57196c91e
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-21T11:48:47Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-5b62a20099a541be9b7374f57196c91e2022-12-21T19:05:07ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882021-02-011110.3389/fcimb.2021.586427586427Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota PerspectiveJiachen Liu0Yantao Xu1Bimei Jiang2Xiangya Medical College of Central South University, Changsha, ChinaXiangya Medical College of Central South University, Changsha, ChinaDepartment of Pathophysiology, Sepsis Translational Medicine Key Laboratory of Hunan Province, Xiangya School of Medicine, Central South University, Changsha, ChinaSince the 1950s, gradual changes in the gut microbiota of patients with hepatic encephalopathy have been observed. Previous research has indicated potential associations between the gut and brain, and the gut microbiota is becoming a hot topic in research on diseases of the nervous system. However, for the past few decades, studies of hepatic encephalopathy have been restricted to controlling the gut microbiota during macroscopic manipulation, such as probiotic intervention, while its clinical use remains controversial, and the cellular mechanisms underlying this condition are still poorly understood. This thesis seeks to comprehensively understand and explain the role of gut microbiota in hepatic encephalopathy as well as analyze the effects of intervention by regulating the gut microbiota. Evidence is presented that shows that dysbiosis of the gut microbiota is the primary pathological driver of hepatic encephalopathy and impacts pathologic progression via complex regulatory networks. As a result, suggestions were identified for future mechanistic research and improvements in therapeutic strategies for hepatic encephalopathy.https://www.frontiersin.org/articles/10.3389/fcimb.2021.586427/fullgut microbiotahepatic encephalopathygut–liver–brain axisprobioticfecal microbiota transplantationantibiotics
spellingShingle Jiachen Liu
Yantao Xu
Bimei Jiang
Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
Frontiers in Cellular and Infection Microbiology
gut microbiota
hepatic encephalopathy
gut–liver–brain axis
probiotic
fecal microbiota transplantation
antibiotics
title Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
title_full Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
title_fullStr Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
title_full_unstemmed Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
title_short Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective
title_sort novel insights into pathogenesis and therapeutic strategies of hepatic encephalopathy from the gut microbiota perspective
topic gut microbiota
hepatic encephalopathy
gut–liver–brain axis
probiotic
fecal microbiota transplantation
antibiotics
url https://www.frontiersin.org/articles/10.3389/fcimb.2021.586427/full
work_keys_str_mv AT jiachenliu novelinsightsintopathogenesisandtherapeuticstrategiesofhepaticencephalopathyfromthegutmicrobiotaperspective
AT yantaoxu novelinsightsintopathogenesisandtherapeuticstrategiesofhepaticencephalopathyfromthegutmicrobiotaperspective
AT bimeijiang novelinsightsintopathogenesisandtherapeuticstrategiesofhepaticencephalopathyfromthegutmicrobiotaperspective